论文部分内容阅读
肥胖与阻塞性睡眠呼吸暂停低通气综合征的相关性研究
【机 构】
：
上海交通大学医学院附属瑞金医院内分泌科 上海市内分泌代谢病临床医学中心 上海市内分泌研究所 200025
【出 处】
：
中华医学会第八次全国内分泌学学术会议
【发表日期】
：
2009年1期
其他文献
Voltage-gated sodium channels play a critical role in the excitability of nociceptors.The effect of a novel diamide compound,HYP-1,on tetrodotoxin sensitive (TTX-S) voltage-gated sodium channels in ra
会议
Background:Non-response of HCV patients to combination therapy has previously been associated with a strong hepatic up-regulation of interferon stimulated genes (ISGs) including ISG 15.Therefore,the a
会议
Recent single molecule experiments have reported that DNA binding proteins (DNA-BPs) can diffuse along DNA [1].This suggests that interactions between proteins and DNA play a role during the target se
会议
Selective Hyper-responsiveness of the Interferon System in Major Depressive Disorders and Depression
Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy.The role of the interferon (IFN)-system in the pathogenesis of major
会议
Development of Multi-Channel Blockers for Management of Atrial Fibrillation-From the Virtual Cell to
Atrial fibrillation (AF) is characterized by disorganized atrial electrical activity and is the most common form of tachyarrhythmia encountered in clinical practice.Primarily a disorder of the elderly
会议
Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and thera
Superparamagnetic iron oxides possess specific magnetic properties in the presence of an external magnetic field,which make them an attractive platform as contrast agents for magnetic resonance imagin
会议
Regulatory T cells (Tregs) have recently taken the limelight as a therapeutic target,because they regulate virtually most adaptive immune responses.In autoimmunity,for example type 1 diabetes or multi
会议
Development of Melanocortin-5 Receptor Antagonists Using a Peptidomimetic Reverse Turn Scaffold:A No
Many peptide ligands adopt a reverse turn secondary structure at the residues that form critical binding interactions with G-protein coupled receptors (GPCRs).Mimetica has developed a series of drug-l